Gene Therapy for Post-Operative Atrial Fibrillation

Withdrawn before enrolling · Phase 1

Conditions studied: Atrial Fibrillation, Post-operative Atrial Fibrillation

In brief

This clinical trial will have 2 components: a brief dose-ranging study and a randomized comparison of 2 doses of AdKCNH2-G628S with control cardiac surgery patients. The study will assess safety of the intervention in a population at increased risk for post-operative atrial fibrillation.

Key facts

Study ID

NCT05223725

Run by

University of Massachusetts, Worcester

People needed

0

Starts

2023-10-01

Expected to finish

2026-08-01

Last updated by the study team

2025-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• UMass Memorial Hospital — Worcester, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.